Peptidetesting

Understand testing before you trust it

Content vs. Purity: What's Really in the Vial?

Purity tells you how large the share of the target peptide is among all detectable components - not how many milligrams are actually inside. The content (assay) measures the absolute amount of active peptide, for example in milligrams. So a vial can be highly pure but still contain less active ingredient than the fill weight suggests.

Peptide Analysis: What Purity, Content, and Identity Mean in a COA

Purity, content, and identity are three values in a certificate of analysis (COA) for peptides, but they tell you different things. Purity describes the relative amount of the target peptide compared to impurities. Content (also called assay) gives the absolute amount of the active ingredient in milligrams. Identity confirms that the amino acid sequence and structure of the molecule are correct.

These three values often appear side by side in a COA, but they measure different aspects of your sample. A high purity level alone doesn't guarantee how much active ingredient is actually in the vial. Likewise, a high content doesn't automatically prove that it's the peptide you wanted. Only the combination of all three values gives you a complete picture of the quality.

Why High Peptide Purity Doesn't Always Mean a Lot of Active Ingredient

A vial can show a purity of 98% and still contain less active peptide than you might expect from the fill weight. That's because purity only reflects the ratio of target peptide to impurities. The absolute amount of active ingredient can be significantly reduced by non-peptide components like water, counterions, or excipients.

In samples with lower purity, incompletely deprotected or truncated peptide fragments also make exact quantification harder. These fragments closely resemble the target peptide but aren't identical. They add to the total mass, but they don't increase the desired amount of active ingredient.

Methods for Determining Content According to ICH Guidelines

The content of your peptide is determined using analytical methods that must be validated according to the internationally recognized ICH guidelines. Each of these methods has specific uses and limitations.

Quantitative HPLC/UV: In this method, the sample is separated on a column and the peptides are detected by UV absorption. Peptide bonds absorb strongly in the range of 210-220 nm, while aromatic side chains respond at 250-290 nm. The content is calculated against an external reference standard. The limitation here is that the UV response depends on the amino acid composition: not every peptide has aromatic residues, and the standard itself must be well characterized.

Amino Acid Analysis (AAA): Here, the sample is hydrolyzed with acid (e.g., 6 M HCl) and the individual amino acids are quantified by LC-MS, which allows an absolute amount to be determined. Difficulties can arise from unstable derivatization steps or residues of scavenger reagents in crude peptides. Also, certified reference peptides are often expensive.

Nitrogen and Elemental Analysis: This measures the nitrogen content of the sample, for example using the Dumas method, to infer the amount of peptide. The downside is that all nitrogen is measured. Nitrogen-containing impurities can therefore falsely inflate the result.

Quantitative NMR (qNMR): This method is currently being explored as an alternative, but it still shows variability in results between different laboratories.

Fill Weight vs. Active Ingredient Content: The Influence of TFA and Counterions

Fill weight describes the total mass of the powder in the vial, consisting of the peptide and all accompanying substances. In synthetic peptide salts, counterions often take up a large portion: trifluoroacetic acid (TFA) can make up to 35% of the weight, chloride up to 10%. Residual solvents and water also add to the mass.

These substances are often unavoidable, coming from the synthesis, or they are deliberately added as excipients (inactive ingredients), for example to improve stability or support lyophilization. According to EMA guidelines, counterions, water, and residual solvents must be reported separately from the assay. The mere fill weight is therefore not a reliable indicator of the actual amount of active ingredient.

What a Content Result Means for Your Dosage

A content result shows the absolute amount of the active peptide in your sample compared to a reference standard, and it forms the basis for the dose. However, it doesn't replace identity tests, which confirm the correct peptide, or purity testing, which rules out impurities.

Also note that content measures the chemical amount but says nothing about biological activity. A peptide can be chemically correct but less effective due to folding or modifications. Separate tests are needed for activity. The assay is an important piece, but only one of several.

Sources

  1. Reference Standards to Support Quality of Synthetic Peptide ...
  2. SURVEY OF PEPTIDE QUANTIFICATION METHODS AND COMPARISON OF THEIR REPRODUCIBILITY: A CASE STUDY USING OXYTOCIN - PMC
  3. Regulatory Guidelines for the Analysis of Therapeutic Peptides and Proteins
  4. Amino acid analysis for peptide quantitation using reversed-phase liquid chromatography combined with multiple reaction monitoring mass spectrometry
  5. Towards a Consensus for the Analysis and Exchange of TFA as a Counterion in Synthetic Peptides and Its Influence on Membrane Permeation
  6. Guideline on the Development and Manufacture of Synthetic Peptides
  7. ICH guideline Q2(R2) on validation of analytical procedures - EMA
  8. Accurate quantitation of standard peptides used for quantitative proteomics
  9. ICH Q6B Specifications: test procedures and acceptance criteria for biotechnological/biological products - Scientific guideline | European Medicines Agency (EMA)
  10. Q6B Specifications: Test Procedures and Acceptance ...
  11. Q 6 B Specifications: Test Procedures and Acceptance Criteria ...
  12. ICH Q2(R2) Validation of analytical procedures - Scientific guideline
  13. Recommendations for the generation, quantification, storage and handling of peptides used for mass spectrometry-based assays
  14. The role of assay methods in characterizing the quality of bulk pharmaceuticals
  15. The Role of Counter-Ions in Peptides—An Overview
  16. Guideline on the Development and Manufacture of Synthetic Peptides
  17. HPLC Analysis and Purification of Peptides - PMC
  18. Evaluation of different isotope dilution mass spectrometry strategies for the characterization of naturally abundant and isotopically labelled peptide standards
  19. Lib 4635 Determination of Crude Protein Content in Diverse Standard ...
  20. Limitations of mass spectrometry-based peptidomic approaches
  21. Facile Preparation of Peptides for Mass Spectrometry Analysis in Bottom‐Up Proteomics Workflows - PMC
  22. Formulation Composition and Process Affect Counterion for ...
  23. Q2(R2) Validation of Analytical Procedures March 2024
  24. Reference Standards to Support Quality of Synthetic ...